Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2019

  • RnM3856010
  • |
  • 20 December, 2019
  • |
  • 1463 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Request a Sample Report



Purchase this Report

$2,500.00
$5,000.00
$7,500.00
1,972.50
3,945.00
5,917.50
2,300.00
4,600.00
6,900.00
387,925.00
775,850.00
1,163,775.00
208,750.00
417,500.00
626,250.00
Credit card Logo